Sampaio C A, Oliva M L, Sampaio M U, Batista I F, Bueno N R, Tanaka A S, Auerswald E A, Fritz H
Departamento de Bioquímica, Escola Paulista de Medicina, UNIFESP, São Paulo, SP, Brazil.
Immunopharmacology. 1996 May;32(1-3):62-6. doi: 10.1016/0162-3109(96)00073-2.
The action of two Bowman-Birk and several plant Kunitz-type inhibitors were studied on trypsin, chymotrypsin, plasma kallikrein and factor XII. The primary structure of some of them was completely defined. The results showed that the Bowman-Birk type inhibitors, although potent inhibitors for trypsin (Ki in the range of 1-2 nM), are not able to inhibit plasma kallikrein. Factor XII (Ki = 1.4 microM) and chymotrypsin (Ki = 5.0 nM) are inhibited by Torresea cearensis trypsin inhibitor (TcTI) but not by Dioclea glabra trypsin inhibitor (DgTI). Both inhibitors reactive site regions are highly homologous, and the amino acid residues in P1 position are the same, Lys and His; major differences are in the charge of the C-terminal portion of the molecules. The studied Kunitz-type inhibitors were all able to inhibit plasma kallikrein (Ki between 4 and 80 nM), with the exception of Schizolobium parahyba chymotrypsin inhibitor (SpCI), that is specific for chymotrypsin. All Kunitz-type inhibitors inactivate chymotrypsin, but with a dissociation constant in the range of 0.1 to 0.6 microM. Factor XIIf is inhibited with Ki in the range of 0.1 microM. Bauhinia bauhinioides trypsin inhibitor (BbTI) did not promote factor XIIf inhibition. The Kunitz-type inhibitors are a highly homologous, sharing 60% identity in the N-terminal portion of the loop containing the reactive site, and 28.6% identity in the C-terminal portion of the same loop.
研究了两种鲍曼-伯克抑制剂和几种植物库尼茨型抑制剂对胰蛋白酶、糜蛋白酶、血浆激肽释放酶和因子 XII 的作用。其中一些抑制剂的一级结构已完全确定。结果表明,鲍曼-伯克型抑制剂虽然是胰蛋白酶的强效抑制剂(Ki 在 1 - 2 nM 范围内),但不能抑制血浆激肽释放酶。托雷西亚卡雷尼斯胰蛋白酶抑制剂(TcTI)可抑制因子 XII(Ki = 1.4 μM)和糜蛋白酶(Ki = 5.0 nM),而光果薯蓣胰蛋白酶抑制剂(DgTI)则不能。两种抑制剂的活性位点区域高度同源,P1 位的氨基酸残基相同,均为赖氨酸和组氨酸;主要差异在于分子 C 端部分的电荷。除了对糜蛋白酶具有特异性的裂叶豆糜蛋白酶抑制剂(SpCI)外,所研究的库尼茨型抑制剂均能抑制血浆激肽释放酶(Ki 在 4 - 80 nM 之间)。所有库尼茨型抑制剂均可使糜蛋白酶失活,但其解离常数在 0.1 - 0.6 μM 范围内。因子 XIIf 被抑制时的 Ki 在 0.1 μM 范围内。羊蹄甲胰蛋白酶抑制剂(BbTI)不能促进因子 XIIf 的抑制。库尼茨型抑制剂高度同源,在包含活性位点的环的 N 端部分有 60%的同一性,在同一环的 C 端部分有 28.6%的同一性。